OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES Stock

Certificat

DE000GG7MQ73

Market Closed - BOERSE MUENCHEN 14:25:42 2024-06-21 EDT
0.18 EUR -1.10% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES
Current month-9.55%
1 month-21.05%
Date Price Change
24-06-21 0.18 -1.10%
24-06-20 0.182 -0.55%
24-06-18 0.183 -3.17%
24-06-17 0.189 -3.57%
24-06-14 0.196 -4.85%

Real-time BOERSE MUENCHEN

Last update June 21, 2024 at 02:25 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Goldman Sachs
WKN GG7MQ7
ISINDE000GG7MQ73
Date issued 2024-05-03
Strike 73.08 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.17
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.236
Lowest since issue 0.171

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
91.51 USD
Average target price
108.2 USD
Spread / Average Target
+18.19%
Consensus